Cost-effectiveness Analysis of Three Therapeutic Schemes for Benign Prostatic Hypertrophy
- VernacularTitle:3种口服给药方案治疗良性前列腺增生症的成本-效果分析
- Author:
Wenyu XU
;
Zhihua TANG
;
Yanzhong YAN
- Publication Type:Journal Article
- Keywords:
Pule’an;
Alfuxosin hydrochloride;
Finasteride;
BPH;
cost-effectiveness analysis
- From:
China Pharmacy
2001;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the economic efficiency of three oral administration schemes in treatment of benign prostatic hypertrophy(BPH).METHODS:73patients with BPH were divided into three groups:group A,Pule’an,group B,Alfuxosin hydrochloride,group C,Finasteride.Data was evaluated using the pharmacoeconomic cost-effectiveness analysis. RESULTS:The effective rates in the group B and group C were higher than that in group A,the effective rate in group B was comparable to that in group C.The cost-effectiveness ratios of A,B,C were1.30,1.80,4.36,respectively.Using sensitivity analysis,the cost-effectiveness ratios were1.17,1.62,3.92,respectively.CONCLUSION:Among the three schemes,scheme B was the best one.
